TBPH icon

Theravance Biopharma

94 hedge funds and large institutions have $722M invested in Theravance Biopharma in 2014 Q2 according to their latest regulatory filings, with 94 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$131K
Puts
$135K
Net Calls
Net Calls Change

Top Buyers

1 +$193M
2 +$66.5M
3 +$66M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$43.7M
5
O
OppenheimerFunds
New York
+$34.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
51
$929K
52
$833K
53
$688K
54
$666K
55
$625K
56
$578K
57
$577K
58
$541K
59
$524K
60
$491K
61
$465K
62
$456K
63
$444K
64
$399K
65
$393K
66
$364K
67
$322K
68
$308K
69
$302K
70
$255K
71
$234K
72
$220K
73
$215K
74
$214K
75
$209K